Comparative Effectiveness of Clinical and Community-Based Approaches to Healthy Weight

Lauren Fiechtner1,2, Meghan Perkins3, Vincent Biggs4

  • 1Division of General Academic Pediatrics, Department of Pediatrics, Massachusetts General Hospital for Children, Boston, Massachusetts lfiechtner@mgh.harvard.edu.

Pediatrics
|September 2, 2021
PubMed

Insights

The Healthy Weight Clinic (HWC) effectively reduced BMI in Hispanic children, while the modified Healthy Weight and Your Child (M-HWYC) intervention did not show significant results. HWC offers a promising pediatric weight management solution.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Behavioral Medicine

Background:

  • Childhood obesity, particularly among low-income Hispanic populations, presents a significant public health challenge.
  • Effective, accessible interventions are crucial for managing pediatric weight and preventing associated comorbidities.
  • Existing pediatric weight management programs require evaluation for efficacy in diverse, underserved communities.

Purpose of the Study:

  • To compare the effectiveness of two pediatric weight management interventions in reducing Body Mass Index (BMI) among Hispanic children.
  • To evaluate if a health center-based Healthy Weight Clinic (HWC) is non-inferior to a community-based modified Healthy Weight and Your Child (M-HWYC) program.
  • To assess the impact of these interventions on BMI and BMI percentile changes in a low-income pediatric population.

Main Methods:

  • A randomized controlled trial involving 407 Hispanic children (aged 6-12 years) with BMI at or above the 85th percentile.
  • Interventions included a Healthy Weight Clinic (HWC) at a health center and a modified Healthy Weight and Your Child (M-HWYC) program at a Young Men's Christian Association (YMCA).
  • Non-inferiority testing was conducted by comparing the change in %BMIp95 between interventions, with a comparison group of 4037 children used for yearly BMI change analysis.

Main Results:

  • The M-HWYC intervention was not found to be non-inferior to the HWC, with a mean difference in %BMIp95 of 0.75 (90% CI: 0.07 to 1.43).
  • Children in the HWC showed a statistically significant decrease in BMI (-0.23 per year) and %BMIp95 (-1.03 per year) compared to the comparison sites.
  • No significant BMI changes were observed in children participating in the M-HWYC intervention.

Conclusions:

  • The modified Healthy Weight and Your Child (M-HWYC) intervention failed to demonstrate non-inferiority to the Healthy Weight Clinic (HWC).
  • The HWC intervention proved effective in improving BMI among participating children, suggesting it is a viable treatment option.
  • The findings highlight the HWC as an effective strategy for pediatric weight management, particularly for disproportionately affected populations.
Abstract

Related Concept Videos

Community Based Intervention01:30

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
123
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
1.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
206
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.3K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
728
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K